QUEST DIAGNOSTICS INC Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUEST DIAGNOSTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in QUEST DIAGNOSTICS INC for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 121.19 | 806 | 97,679 | 41,695 | 42.5 K to 41.7 K (-1.90 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 121.15 | 1,250 | 151,438 | 42,501 | 43.8 K to 42.5 K (-2.86 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 121.19 | 103 | 12,483 | 25,601 | 25.7 K to 25.6 K (-0.40 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 121.15 | 159 | 19,263 | 25,704 | 25.9 K to 25.7 K (-0.61 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 121.19 | 611 | 74,047 | 23,213 | 23.8 K to 23.2 K (-2.56 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 121.15 | 1,017 | 123,210 | 23,824 | 24.8 K to 23.8 K (-4.09 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 121.19 | 541 | 65,564 | 77,873 | 78.4 K to 77.9 K (-0.69 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 121.15 | 830 | 100,555 | 78,414 | 79.2 K to 78.4 K (-1.05 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Payment of Exercise | F | 121.19 | 3,319 | 402,230 | 251,946 | 255.3 K to 251.9 K (-1.30 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Payment of Exercise | F | 121.15 | 4,033 | 488,598 | 255,265 | 259.3 K to 255.3 K (-1.56 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 121.19 | 524 | 63,504 | 71,032 | 71.6 K to 71 K (-0.73 %) |
| Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 121.15 | 796 | 96,435 | 71,556 | 72.4 K to 71.6 K (-1.10 %) |
| Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Option Exercise | A | 121.81 | 27,633 | 3,365,838 | 27,633 | |
| Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Option Exercise | A | 121.81 | 27,633 | 3,365,838 | 27,633 | |
| Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Option Exercise | A | 121.81 | 27,633 | 3,365,838 | 27,633 | |
| Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Grant | A | 0.00 | 4,926 | 0 | 29,045 | 24.1 K to 29 K (+20.42 %) |
| Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Grant | A | 0.00 | 4,926 | 0 | 29,045 | 24.1 K to 29 K (+20.42 %) |
| Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Grant | A | 0.00 | 4,926 | 0 | 29,045 | 24.1 K to 29 K (+20.42 %) |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Option Exercise | A | 121.81 | 120,901 | 14,726,346 | 120,901 | |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Grant | A | 0.00 | 21,551 | 0 | 259,298 | 237.7 K to 259.3 K (+9.06 %) |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | A | 121.81 | 17,958 | 2,187,374 | 17,958 | |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 3,202 | 0 | 43,289 | 40.1 K to 43.3 K (+7.99 %) |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Option Exercise | A | 121.81 | 4,003 | 487,585 | 4,003 | |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Grant | A | 0.00 | 715 | 0 | 25,863 | 25.1 K to 25.9 K (+2.84 %) |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Option Exercise | A | 121.81 | 31,774 | 3,870,232 | 31,774 | |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Grant | A | 0.00 | 5,665 | 0 | 79,244 | 73.6 K to 79.2 K (+7.70 %) |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 121.81 | 22,105 | 2,692,500 | 22,105 | |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 3,941 | 0 | 72,352 | 68.4 K to 72.4 K (+5.76 %) |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | A | 121.81 | 31,774 | 3,870,232 | 31,774 | |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Grant | A | 0.00 | 5,665 | 0 | 43,751 | 38.1 K to 43.8 K (+14.87 %) |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Option Exercise | A | 121.81 | 27,633 | 3,365,838 | 27,633 | |
| Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Grant | A | 0.00 | 4,926 | 0 | 24,841 | 19.9 K to 24.8 K (+24.74 %) |